Form 4: Apellis Pharmaceuticals VP James Chopas Sells Shares to Cover Tax Withholding

James George Chopas, VP/Chief Accounting Officer of Apellis Pharmaceuticals, sold 1,096 shares of common stock on January 22, 2025, to cover tax withholding obligations.

Summary

• On January 22, 2025, James George Chopas, VP/Chief Accounting Officer of Apellis Pharmaceuticals, sold 1,096 shares of the company's common stock.
• The sale was executed at a price of $30.4255 per share.
• This transaction was to cover tax withholding on Restricted Stock Units released on January 21, 2025.
• Following the transaction, Chopas directly owns 48,138 shares of Apellis Pharmaceuticals.

Sentiment

Score: 5

Explanation: This is a neutral event. It's a routine transaction to cover tax obligations and doesn't necessarily indicate a positive or negative outlook on the company.

Industry Context

This is a routine Form 4 filing, indicating an insider transaction. It's common for executives to sell shares to cover tax obligations related to stock-based compensation.

Stakeholder Impact

• The sale of shares by an officer could have a minor impact on shareholder sentiment, but is unlikely to be significant given the context of tax withholding.

Key Dates

Keywords

Apellis Pharmaceuticals, James Chopas, stock sale, Form 4, insider trading, tax withholding, APLS